Clinical Trial Update: Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical study is evaluating an mTOR inhibitor as a treatment for grey hair (canities); the trial status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Grey Hair

Drugs mentioned

• mTOR inhibitor

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Canities, Grey Hair | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING